Neonatal transition and oxygenation monitoring
Clinical context for the first minutes after birth.
Scientific foundation
NeoPerfuse builds on optical sensing, multispectral photodetection, neonatal monitoring, signal-quality assessment, and translational medtech development.
Disclosure note
Some publications, patent details, and ownership/licensing information are placeholders and must be confirmed before public disclosure.
The scientific basis of NeoPerfuse includes neonatal transition monitoring, pulse oximetry limitations under difficult conditions, multispectral optical sensing, NIR/SWIR-adjacent detector concepts, and AI-based signal-quality assessment.
Clinical context for the first minutes after birth.
Reference workflows and target ranges subject to local protocols.
Known limitations affecting interpretability.
Additional spectral information for signal-quality assessment.
Detector concepts informing future multispectral exploration.
Clinically understandable SQI and failure-mode logic.
Reports a solution-processed organic NIR/SWIR photodetector concept relevant to detector-level optical sensing research.
Source information
This exploratory delivery-room study investigates whether the Oxygenation Ratio (SpO₂/FiO₂) can help distinguish early oxygenation patterns in very preterm infants and support more actionable oxygen titration during the first minutes after birth.
very preterm infants · delivery room · oxygenation · SpO₂/FiO₂ · bedside decision support
External citation record for an organic electronics publication.
External citation record for a solution-processed organic transistor publication.
External citation record for a flexible electronics publication.
External citation record for a printed quantum-dot solar cell publication.
External citation record for an infrared photodetector publication.
This patent family is treated as potential background IP for detector-level differentiation. It should not be described as already protecting the complete neonatal application, AI-based Signal Quality Index, or medical workflow claim unless confirmed by patent counsel.
View patent applicationCollaboration
We welcome discussion with academic, clinical, technology-transfer, and medtech partners.